Wincom Company Ltd.
Main products:Centrifuge,Microscope,First-Aid Case,Electronic Balance,Magnetic Stirrer Hot Plate
Products
Contact Us
  • Contact Person : Ms. Huang Judy
  • Company Name : Wincom Company Ltd.
  • Tel : 86-731-88660686
  • Fax : 86-731-84121122
  • Address : Hunan,CHANGSHA,NO.46,MINGCHENG INTERNATIONAL,RENMING ROAD(E)
  • Country/Region : China
  • Zip : 410005

GMP ISO Etamsylate CAS NO.2624-44-4

GMP ISO Etamsylate CAS NO.2624-44-4
Product Detailed
1.Etamsylate CAS NO.2624-44-4 2.BP,CP 3.Self life:2 years 4.Sample available

Etamsylate (Dicynene/Dicynone) is a haemostatic drug.

Synonyms: 1-hydroxy-4-oxo-2,5-cyclohexadiene-1-sulfonicacidcompd.withdiethylamine;2,5-dihydroxy-benzenesulfonicacicompd.withdiethylamine;2,5-dihydroxy-benzenesulfonicacicompd.withn-ethylethanamine(1:1);2,5-dihydroxybenzenesulfonicacidcompd.withn-ethylethanamine;2,5 DihydroxybenzenesulfonicacidcompdwithN-ethylethanamine;aglumin;altodor;ciclonamina

                                                               COA

Item

Specification

Characters

A white or almost white crystalline powder

Solubility

Very soluble in water, freely soluble in Methanol, soluble in ethanol, practically insoluble in methylene chloride

Identification

Meet the requirements

Melting Point

127 ~ 134°C

Appearance of solution

Clear and Clourless

PH

4.5 ~ 5.6       

Related Substances

Impurity A

≤0.10%

Unspecified Impurities

≤0.10%

Total Impurity

≤0.20%

Heavy Metals

≤15ppm

Iron

≤15ppm

Loss on drying

≤0.5%

Sulfated Ash

≤0.1%  

Assay (on dried basis)

99.0 ~ 101.0%

About Us

----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Need help?Please contact us!

GMP ISO Etamsylate CAS NO.2624-44-4



Copyright Notice @ 2008-2022 ECOL Limited and/or its subsidiaries and licensors. All rights reserved.